Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025 Compelling kidney function data from VIVIAD Phase 2b study ...
Kidneys are one of the most important organs of the body, that filter waste and toxins, and keep us healthy. With age, poor ...
High blood sugar signals kidney strain. Consistently elevated glucose levels damage kidney filters and blood vessels. This ...
The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the ...
These findings underscore the limitations of relying on proteinuria alone to assess LN treatment success and demonstrate the clinical utility of biomarker-guided risk stratification.
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value ...
The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction ...
Chronic kidney disease (CKD) is a progressive condition in which the kidneys gradually lose their ability to filter waste from the blood. It is a common health concern that affects an estimated 8–16% ...
Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced new data from the Phase 3 DUPLEX Study demonstrating that patients with focal segmental glomerulosclerosis (FSGS) treated with FILSPARI® ...
Reduced kidney function from chronic kidney disease may undermine the accuracy of blood-based biomarkers used to predict AD outcomes.
Serum urate (SU) levels rise sharply during the menopausal transition and remain elevated thereafter, suggesting that the risk for hyperuricemia and subsequent gout among women may begin years before ...
The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback